Program Schedule

Treatment of Antimicrobial Resistant Infections

Thursday, October 9, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Health care workers, HIV clinicians, HIV specialists, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, HIV-STD-TB, Investigative ID, Pediatric ID

Analysis of Clinical and Economical Outcomes of Fidaxomicin Use for Clostridium difficile infections
Sarah Flaherty, PharmD ; John Lock, PharmD ; Markian Bochan, MD, PhD, FIDSA
RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
Erik Dubberke, MD, MSPH ; Robert Orenstein, DO ; Paul Mariani, MD ; Kathleen Mullane, DO, FIDSA ; Mary Kay Sobcinski, RN, MHA
Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
Rodrigo E. Mendes, PhD ; Helio S. Sader, MD, PhD ; Robert K. Flamm, PhD ; David J. Farrell, PhD ; Ronald N. Jones, MD
Ceftaroline-induced Neutropenia: Two Case Reports
Kelly E. Martin, PharmD ; Lisa E. Davidson, MD
Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
Natasha Pettit, PharmD ; Jennifer Delacruz, MD, MS ; Zhe Han, PharmD ; Emily Landon, MD ; Jennifer Pisano, MD
Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
Rodrigo E. Mendes, PhD ; Helio S. Sader, MD, PhD ; Robert K. Flamm, PhD ; David J. Farrell, PhD ; Ronald N. Jones, MD
Heterogeneous Vancomycin-Intermediate Coagulase-Negative Staphylococci in Neonates: Does treatment with Linezolid improve outcomes?
Ana Chelčne Blanchard, MDCM ; Céline Laferričre, MD ; Isabelle Goyer, Pharm / Msc ; Philippe Ovetchkine, MD ; Ahmed Moussa, MD ; Beatrice Da Silva, Medical Student ; Jasmine Swet Yee Chong, BSc Microbiology ; Caroline Quach, MD MSc
  • ID Week 2014.pdf (1.9 MB)
  • 477
    In vitro Synergy Testing of Daptomycin with Beta-lactams, Gentamicin, Rifampin and Tigecycline against Daptomycin Non-Susceptible Enterococci
    Theodoros Kelesidis, MD, PhD ; Janet a. Hindler, MCLS, MT ; Annie Wong-Beringer, PharmD ; Marissa Carvalho ; Myra Maldonado ; Romney M. Humphries, Ph.D.
    Daptomycin Susceptible versus Nonsusceptible Enterococcus faecium Bacteremias: Comparison of Clinical and Microbiological Outcomes
    Spencer Lee, Pharm.D. ; Gary Wu, Pharm.D. ; Teena Abraham, M.S., Pharm.D. ; Nasser Saad, Pharm.D. ; Natalya Goldshteyn, M.D. ; Roseanni Andrescavage, B.S.
  • IDWeek_ EFaecium Poster.pdf (517.9 kB)
  • 480
  • IDSA.pdf (419.6 kB)
  • 486
  • MERINO IDSA poster.pdf (240.7 kB)
  • 487
    Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
    Cely Saad Abboud, MD ; David Jacobs, PharmD ; Jussimara Monteiro, PhD ; Eliana De Cassia Zandonadi, RN ; Vera Lucia Barbosa ; Alan Forrest, PharmD ; Gauri Rao, PharmD
    Treatment Outcomes in Patients with Extended-Spectrum Beta-lactamase Producing Organisms
    Eunbae Lee, PharmD ; Susan Butler-Wu, PhD ; Paul Pottinger, MD ; Moni Blazej Neradilek ; Rupali Jain, PharmD
    Accuracy of Clinicians' Empiric Treatment Choices for Resistant Gram-Negative Uropathogens
    Katherine Linsenmeyer, MD ; Judith Strymish, MD ; Kalpana Gupta, MD, MPH
    High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
    Sharon Sam, PharmD ; Lisa Russell, MD ; Katy Guo, PharmD Candidate ; Kim Rusche, PharmD Candidate
    Comparative Effectiveness of Single Versus Combination Antibiotic Prophylaxis for TRUS-biopsy
    Kaylee Marino, PharmD ; Judith Strymish, MD ; Anne Parlee, PharmD ; Lori Lerner, MD ; Ralph Orlando, MD ; Kalpana Gupta, MD, MPH
  • VA research day poster.pdf (153.9 kB)
  • 492
    Complicated Intra-abdominal Infection (cIAI) and 30-day Hospital Readmission
    Jon P. Furuno, PhD ; Brie N. Noble, BS ; David T. Bearden, PharmD ; Miriam R. Elman, MPH ; Michael S. Sisson, BS ; Jessina C. Mcgregor, PhD
  • colistin in neonates.jpg (1.7 MB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek